drugset / Trial / NCT02856178
Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients
NaSingle-groupOpen-labelPrevention
Summary
This study assesses the pharmacokinetics and safety of the new antifungal F901318 in AML patients.
Timeline
- Start
- 2017-04-20
- Primary completion
- 2017-04-20
- Completion
- 2017-04-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olorofim | Small molecule | 2 mg/kg | Intravenous |
| Background | Caspofungin | Other / unclassified | 50 mg | Intravenous |